Liqun Wei, Yi-Mei Zhang, Xiao-Le Yin, Xuan Zhang, Bing Zhang, Jimin Fan, Zhihuan Zhao, Min Xu
{"title":"Green-Reduced Biodegradable Core-Shell Smart-Responsive MOFs for Photothermal-Enhanced Chemo-Chemodynamic in Tumor Catalysis Therapy.","authors":"Liqun Wei, Yi-Mei Zhang, Xiao-Le Yin, Xuan Zhang, Bing Zhang, Jimin Fan, Zhihuan Zhao, Min Xu","doi":"10.1021/acs.molpharmaceut.5c00328","DOIUrl":null,"url":null,"abstract":"<p><p>Metal-organic frameworks (MOFs) have been widely developed for the treatment of malignant tumors due to their high porosity, ease of functionalization, and smart-responsive degradation. Herein, a core-shell nanocomposite PAZDH (HA@DOX-PDA@Bio-Ag/ZIF-8) based on polydopamine (PDA)-coated green-reduced silver nanoparticles (Bio-Ag NPs) loaded on zeolite imidazolium framework-8 (ZIF-8) is designed, which can trigger near-infrared light (NIR)-enhanced chemodynamic reaction and chemotherapy for effective tumor treatment. Due to the targeting of the shell to the CD44 receptor, which is overexpressed in tumor cells, PAZDH NPs can actively aggregate at the tumor site. Subsequently, based on the pH-sensitive degradation of the core, this nanocomposite can release Bio-Ag NPs and doxorubicin (DOX) in a smart-responsive manner. Moreover, Bio-Ag NPs prepared by the green-reduced method using plant extract have a particle size of 40 nm, which can easily enter the tumor cells by endocytosis and induce apoptosis by catalyzing the production of cytotoxic ·OH from H<sub>2</sub>O<sub>2</sub> enriched in the TME. Importantly, the high temperature generated by PTT can promote the release of DOX and accelerate the generation rate of ·OH, enabling photothermal-enhanced chemo-chemodynamic therapy. The PAZDH NPs can efficiently induce tumor ablation and inhibit solid tumors by up to 91.72%. In conclusion, this study provides a promising strategy for the development of smart-responsive MOFs in the field of tumor treatment.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00328","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Metal-organic frameworks (MOFs) have been widely developed for the treatment of malignant tumors due to their high porosity, ease of functionalization, and smart-responsive degradation. Herein, a core-shell nanocomposite PAZDH (HA@DOX-PDA@Bio-Ag/ZIF-8) based on polydopamine (PDA)-coated green-reduced silver nanoparticles (Bio-Ag NPs) loaded on zeolite imidazolium framework-8 (ZIF-8) is designed, which can trigger near-infrared light (NIR)-enhanced chemodynamic reaction and chemotherapy for effective tumor treatment. Due to the targeting of the shell to the CD44 receptor, which is overexpressed in tumor cells, PAZDH NPs can actively aggregate at the tumor site. Subsequently, based on the pH-sensitive degradation of the core, this nanocomposite can release Bio-Ag NPs and doxorubicin (DOX) in a smart-responsive manner. Moreover, Bio-Ag NPs prepared by the green-reduced method using plant extract have a particle size of 40 nm, which can easily enter the tumor cells by endocytosis and induce apoptosis by catalyzing the production of cytotoxic ·OH from H2O2 enriched in the TME. Importantly, the high temperature generated by PTT can promote the release of DOX and accelerate the generation rate of ·OH, enabling photothermal-enhanced chemo-chemodynamic therapy. The PAZDH NPs can efficiently induce tumor ablation and inhibit solid tumors by up to 91.72%. In conclusion, this study provides a promising strategy for the development of smart-responsive MOFs in the field of tumor treatment.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.